摘要:
A mobile communications handset (12) is capable of connection through two different networks (2, 27). When it is out of contact with its preferred local wireless access system (27), the handset will seek a hand-over to the cellular network (2), and will become registered as a “roaming” handset currently connected to the cellular network (2). The cellular network (2) reports this location information to the call server (28), as it would to the HLR of any normal visiting handset, so that incoming calls to the PSTN (6) destined for the user (12) can be routed by way of the cellular network. Outgoing calls are handled as conventional cellular telephony calls. When contact with a local wireless access system (27) is re-established, the contact information is passed to the call server 28, which reports to the cellular network (2) that a handover has occurred. An interface between the call server (28) and cellular network (2) is configured such that the call server (28) emulates a base site controller of the cellular network (2). The cellular network therefore operates conventionally, with the handset (12) logged as operating through this quasi-base site controller. However, the cellular system would continue to register the presence of the handset as co-operating with the quasi-base station (28), even though it would have no visibility of most calls being made to and from the handset (12). This avoids the cellular system (2) attempting to seize control of the handset through a normal cellular base station (21).
摘要:
This invention features devices and methods for inducing tissue formation in a mammal, involving the use of a morphogenic protein, a hormone and a soluble receptor of the hormone. The hormone and receptor thereof are used to enhance the tissue inductive activity of the morphogenic protein.
摘要:
The present invention provides pharmaceutical compositions comprising a morphogenic protein stimulatory factor (MPSF) for improving the tissue inductive activity of morphogenic proteins, particularly those belonging to the BMP protein family. Methods for improving the tissue inductive activity of a morphogenic protein in a mammal using those compositions are provided. This invention also provides implantable morphogenic devices comprising a morphogenic protein and a MPSF disposed within a carrier, that are capable of inducing tissue formation in allogeneic and xenogeneic implants. Methods for inducing local tissue formation from a progenitor cell in a mammal using those devices are also provided. A method for accelerating allograft repair in a mammal using morphogenic devices is provided. This invention also provides a prosthetic device comprising a prosthesis coated with a morphogenic protein and a MPSF, and a method for promoting in vivo integration of an implantable prosthetic device to enhance the bond strength between the prosthesis and the existing target tissue at the joining site. Methods of treating tissue degenerative conditions in a mammal using the pharmaceutical compositions are also provided.
摘要:
The present invention provides pharmaceutical compositions comprising a morphogenic protein stimulatory factor (MPSF) for improving the tissue inductive activity of morphogenic proteins, particularly those belonging to the BMP protein family. Methods for improving the tissue inductive activity of a morphogenic protein in a mammal using those compositions are provided. This invention also provides implantable morphogenic devices comprising a morphogenic protein and a MPSF disposed within a carrier, that are capable of inducing tissue formation in allogeneic and xenogeneic implants. Methods for inducing local tissue formation from a progenitor cell in a mammal using those devices are also provided. A method for accelerating allograft repair in a mammal using morphogenic devices is provided. This invention also provides a prosthetic device comprising a prosthesis coated with a morphogenic protein and a MPSF, and a method for promoting in vivo integration of an implantable prosthetic device to enhance the bond strength between the prosthesis and the existing target tissue at the joining site. Methods of treating tissue degenerative conditions in a mammal using the pharmaceutical compositions are also provided.
摘要:
A system and method of remotely recording a telephone message at a selected recording device connected to a telephone receiver by an RF link may include a base station having an RF transmitter connected to a telephone receiver, and plural paging/recording devices, each with an RF receiver and a message recorder. The paging/recording devices may be contained within suitable children's toys, or within pager-like packages. A caller calls the telephone receiver and when the telephone connection has been made provides a first code signal to the telephone receiver to gain access to the RF transmitter, and then provides a second code signal to identify a particular paging/recording device that is to receive and record the message.
摘要:
A method of inhibiting the 5-lipoxygenase pathway in an animal in need thereof which comprises administering an effective, 5-lipoxygenase pathway inhibiting amount of a diaryl-substituted imidazole fused to a thiazole pyrrolidine, thiazide or piperidine ring to such animal.
摘要:
A method of routing call signalling to a destination address from a first cellular mobile communications network comprising a plurality of cells to one of a plurality of smaller cells collectively identified in said first mobile communications network by a single virtual cell identifier. The method involves receiving call signalling for a call in a first routing domain associated with said first mobile communications network, and then determining in said first routing domain from said destination address a forwarding address for said call signalling, wherein said forwarding address comprises said virtual cell identifier, forwarding said call signalling to a network gateway node associated with said virtual cell identifier in said first routing domain, said gateway node being further arranged to participate in a different routing domain by identifying, using said different routing domain, the identity of one of said smaller cells associated with said destination address; and finally, routing the call signalling to said destination address.